Back to mobile site

More on PVLA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/13/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Palvella Therapeutics (NQ:PVLA)
Delayed: 108.81 +2.43 (2.28%)
Prev. Close $106.38  
Open$106.82 
52 Wk High$ 
52 Wk Low$ 
Day High$109.01 
Day Low$104.77 
P/E N/A  
EPS$ 
Volume360,812 

Friends, Peers and Foes (?): PI6, KRYS, ARQT, 0ACX, INCY (more...)

Jun 12, 2026 04:08 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: KIRITSY CHRISTOPHER P
Jun 12, 2026 04:08 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: JENKINS GEORGE M
Jun 12, 2026 04:07 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: HERON ELAINE J
Jun 12, 2026 04:07 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: Doux John
Jun 12, 2026 04:07 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: Davis Todd C
Jun 12, 2026 04:06 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: Wessel Tadd S.
Jun 9, 2026 08:43 AM ResVita Bio adds dermatologist John Doux to board of directors
Jun 9, 2026 08:43 AM ResVita Bio Appoints John D. Doux, M.D., M.B.A., to Board of Directors
Jun 3, 2026 07:30 AM Palvella Therapeutics completes FDA pre-NDA meeting for QTORIN rapamycin
Jun 3, 2026 07:30 AM Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN™ Rapamycin in Microcystic Lymphatic Malformations
View All Articles

Entities mentioned with PVLA

View All Entities